Reaction Details |
| Report a problem with these data |
Target | Bromodomain-containing protein 3 |
---|
Ligand | BDBM50365463 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1469308 (CHEMBL3414205) |
---|
IC50 | 400±n/a nM |
---|
Citation | Zhao, L; Wang, Y; Cao, D; Chen, T; Wang, Q; Li, Y; Xu, Y; Zhang, N; Wang, X; Chen, D; Chen, L; Chen, YL; Xia, G; Shi, Z; Liu, YC; Lin, Y; Miao, Z; Shen, J; Xiong, B Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimization. J Med Chem58:1281-97 (2015) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Bromodomain-containing protein 3 |
---|
Name: | Bromodomain-containing protein 3 |
Synonyms: | BRD3 | BRD3_HUMAN | Bromodomain and extra-terminal motif (BET) | Bromodomain-containing protein 3 | Bromodomain-containing protein 3 (BRD3) | KIAA0043 | RING3-like protein | RING3L |
Type: | Protein |
Mol. Mass.: | 79571.81 |
Organism: | Homo sapiens (Human) |
Description: | Q15059 |
Residue: | 726 |
Sequence: | MSTATTVAPAGIPATPGPVNPPPPEVSNPSKPGRKTNQLQYMQNVVVKTLWKHQFAWPFY
QPVDAIKLNLPDYHKIIKNPMDMGTIKKRLENNYYWSASECMQDFNTMFTNCYIYNKPTD
DIVLMAQALEKIFLQKVAQMPQEEVELLPPAPKGKGRKPAAGAQSAGTQQVAAVSSVSPA
TPFQSVPPTVSQTPVIAATPVPTITANVTSVPVPPAAAPPPPATPIVPVVPPTPPVVKKK
GVKRKADTTTPTTSAITASRSESPPPLSDPKQAKVVARRESGGRPIKPPKKDLEDGEVPQ
HAGKKGKLSEHLRYCDSILREMLSKKHAAYAWPFYKPVDAEALELHDYHDIIKHPMDLST
VKRKMDGREYPDAQGFAADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDEPV
EAPALPAPAAPMVSKGAESSRSSEESSSDSGSSDSEEERATRLAELQEQLKAVHEQLAAL
SQAPVNKPKKKKEKKEKEKKKKDKEKEKEKHKVKAEEEKKAKVAPPAKQAQQKKAPAKKA
NSTTTAGRQLKKGGKQASASYDSEEEEEGLPMSYDEKRQLSLDINRLPGEKLGRVVHIIQ
SREPSLRDSNPDEIEIDFETLKPTTLRELERYVKSCLQKKQRKPFSASGKKQAAKSKEEL
AQEKKKELEKRLQDVSGQLSSSKKPARKEKPGSAPSGGPSRLSSSSSSESGSSSSSGSSS
DSSDSE
|
|
|
BDBM50365463 |
---|
n/a |
---|
Name | BDBM50365463 |
Synonyms: | CHEMBL1232461 |
Type | Small organic molecule |
Emp. Form. | C22H22ClN5O2 |
Mol. Mass. | 423.895 |
SMILES | CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc12 |r,t:7| |
Structure |
|